11 November 2021 - To 7 November 2021, the TGA has received 288 reports which have been assessed as likely to be myocarditis from about 22.7 million doses of Comirnaty (Pfizer).
For Vaxzevria (AstraZeneca), two new cases of thrombosis with thrombocytopenia syndrome were reported this week, taking the total to 160.